[1]
|
Zaganjor, I., Sekkarie, A., Tsang, B.L., Williams, J., Razzaghi, H., Mulinare, J., et al. (2016) Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. PLoS ONE, 11, 1-31.
https://doi.org/10.1371/journal.pone.0151586
|
[2]
|
Larijani, F.J., Moghtaderi, M., Hajizadeh, N. and Assadi, F. (2013) Preventing Kidney Injury in Children with Neurogenic Bladder Dysfunction. International Journal of Preventive Medicine, 12, 1359-1364.
|
[3]
|
Boulet, S.L., Yang, Q., Mai, C., et al. (2008) Trends in the Postfortification Prevalence of Spina Bifida and Anencephaly in the United States. Birth Defects Research, 82, 527-532. https://doi.org/10.1002/bdra.20468
|
[4]
|
Manning, S.M., Jennings, R. and Madsen, J.R. (2000) Pathophysiology, Prevention and Potential Treatment of Neural Tube Defects. Mental Retardation and Developmental Disabilities Research Reviews, 6, 6-14.
https://doi.org/10.1002/(SICI)1098-2779(2000)6:1<6::AID-MRDD2>3.0.CO;2-B
|
[5]
|
Brau, R.H., Rodriquez, R., Ramirez, M.V., Gonzalez, R. and Martinez, V. (1990) Experience in Management of Myelomeningocele in Puerto Rico. Journal of Neurosurgery, 72, 726-731. https://doi.org/10.3171/jns.1990.72.5.0726
|
[6]
|
Steinbok, P., Irvine, B. and Cochrane, D.D. (1992) Long-Term Outcome and Complication of Children Born with Myelomeningocele. Child’s Nervous System, 8, 92-96. https://doi.org/10.1007/BF00298448
|
[7]
|
Greene, W.B., Terry, R.C., DeMasi, R.A. and Herrington, R.T. (1991) Effect of Race and Gender on Neurological Level in Myelomeningocele. Developmental Medicine & Child Neurology, 33, 110-117. https://doi.org/10.1111/j.1469-8749.1991.tb05089.x
|
[8]
|
Ketabchi, S.E., Ghodsi, S.M. and Nejat, F. (2001) Incidence of Anomalies in Newborns at Two Obstetric Centers in Tehran. Journal of Medical Council of Iran, 18, 277-281.
|
[9]
|
Czeizel, A.E. and Dudas, I. (1992) Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation. The New England Journal of Medicine, 327, 1832-1835.
|
[10]
|
Czeizel, A.E. (1993) Prevention of Congenital Abnormalities by Periconceptional Multivitamin Supplementation. BMJ, 306, 1645-1648.
https://doi.org/10.1136/bmj.306.6893.1645
|
[11]
|
Kadir, R.Z., Sabin, C., Whitlow, B., Brockbank, E. and Economides, D. (1999) Neural Tube Defects and Periconceptional Folic Acid in England and Wales: Retrospective Study. BMJ, 319, 92-93. https://doi.org/10.1136/bmj.319.7202.92
|
[12]
|
Jensen, L.E., Hoess, K., Whitehead, A.S. and Mitchell, L.E. (2005) The NAT1 C1095A Polymorphism, Maternal Multivitamin Use and Smoking, and the Risk of Spina Bifida. Birth Defects Research: Part A, Clinical and Molecular Teratology, 73, 512-516. https://doi.org/10.1002/bdra.20143
|
[13]
|
Bier, J.B., Morales, Y., Liebling, J., Geddes, L. and Kim, E. (1997) Medical and Social Factors Associated with Cognitive Outcome in Individuals with Myelomeningocele. Developmental Medicine & Child Neurology, 39, 263-266.
https://doi.org/10.1111/j.1469-8749.1997.tb07423.x
|
[14]
|
Northrup, H. and Volcik, K.A. (2000) Spina Bifida and Other Neural Tube Defects. Current Problems in Pediatric and Adolescent Health Care, 30, 315-337.
|
[15]
|
Skari, H., Bjornland, K., Bjornstad-Ostensen, A., Haugen, G. and Emblem R. (1998) Consequences of Prenatal Diagnosis: A Preliminary Report on Neonates with Congenital Malformations. Acta Obstetricia et Gynecologica Scandinavica, 77, 635-642.
https://doi.org/10.1034/j.1600-0412.1998.770610.x
|